BMRA Biomerica Inc.

Biomerica Inc develops, manufactures, and markets medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions.

As of 05/07/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  12,302,157
Average volume:  122,417
Market cap:   $53,391,361
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    09061H307
ISIN:        US09061H3075
Sedol:      2618520
Valuation   (See tab for details)
PE ratio:   -9.91
PB ratio:   5.10
PS ratio:   6.02
Return on equity:   -37.52%
Net income %:   -44.83%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy